The group’s principal activity is to provide pharmaceutical product and services. The group’s operates through two segments namely pharmaceutical products and royalties. The products of the group include DAYTRANA, ELAPRASE, PENTASA, REPLAGAL and AGRYLIN. The group operates from the United Kingdom and North America. Of the total revenue in the year 2006, pharmaceutical products accounted for $1,535.8 and royalties $242.9 (millions)
